Overview
Status
Active
Registry date
2017-03-24
Share capital
5,000.00 PLN
Registered address
ul. Wenecjańska 7/104, 61-101 Poznań, Poland
Electronic delivery address
AE:PL-62065-63046-RHCER-26
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 371 days for 2021).
- 202527/07/2026
- 202410/07/2025
- 202329/07/2024
- 202221/07/2023
- 202121/07/2023
- 202005/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Aleksander Piotr Psztur – Management Board Member
Przemysław Igel – Management Board Member
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Fundacja Rodzinna Aleksandra Psztura | 50 | $675.31 | 50% |
Fundacja Rodzinna Igel | 50 | $675.31 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Poznańskie Zakłady Zielarskie HerbapolS.A. | $31,668,225.77 | herbapol.poznan.pl | ||
| Curtis Health CapsS.A. | $30,831,117.38 | chc.com.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2024-01-19 | Address change (Ul. Święty Marcin 29/8, 61-806, Poznań → Ul. Wenecjańska 7/104, 61-101, Poznań) | |
| 2019-09-04 | Address change (Ul. Masztalarska 6/4, 61-767, Poznań → Ul. Święty Marcin 29/8, 61-806, Poznań) | |
| 2019-09-04 | Name change (Intelligent Healthcare Systems → Medplant Pharmaceuticals) | |
| 2019-09-04 | PKD change (Removed: 8 codes; Added: 8 codes) | |
| 2017-03-24 | Entered in the register |
FAQ
The main business activity of Medplant Pharmaceuticals focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on March 24, 2017.
The headquarters is located at: ul. Wenecjańska 7, 61-101 Poznań.
The management board consists of: Aleksander Piotr Psztur (Member of the Management Board) and Przemysław Igel (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
Yes, the company recorded a net profit of $0 in 2025.
Last updated: 2026-07-27